Cardiac amyloidosis in India: Experience from a single tertiary care center

Author:

Vivek B.S1,Patel Rohan1,Jain Ashish Kumar1,Sawhney J.P.S.1,Jain Rajneesh1,Passey Rajiv1,Mehta Ashwani1

Affiliation:

1. Department of Cardiology, Dharma Vira Heart Centre, Sir Gangaram Hospital, New Delhi, India

Abstract

Abstract PURPOSE: Cardiac amyloidosis (CA) is perceived as a rare disease. Identifying certain red flag signs in patients helps in early diagnosis of CA. Epidemiology of CA in India is not well known. We performed this study to determine various demographic, clinical, and imaging parameters of patients diagnosed with CA in a tertiary care center in India. METHODS: We prospectively screened 48 patients between January 2021 and December 2023 with one or more red flags signs of CA. Their demographic, clinical, and imaging parameters were analyzed. RESULTS: Among 48 patients with one or more red flag signs, CA was diagnosed in 23 patients (47.91%). Seventeen patients were found to have AL CA and 6 had ATTR CA. The mean age of patients was 62.2 years with slight male preponderance (n = 13, 56.5%). All the patients presented with heart failure with the majority in New York Heart Association Class III (n = 11, 47.8%). The most common electrocardiogram abnormality was low-voltage QRS complexes in limb leads (56.5% of patients). Common echocardiographic abnormalities were left ventricular hypertrophy (100%), biatrial enlargement (100%), and reduced global longitudinal strain with relative apical sparing (cherry on top appearance) (74%). Tc99-PYP bone scintigraphy was done in 16 patients. It showed grade 2 uptake in all ATTR CA patients and 6 out of 11 in AL CA patients.Cardiovascular magnetic resonance was done in 5 AL CA patients. The most typical finding was diffuse subendocardial late gadolinium enhancement. CONCLUSIONS: There are significant lacunae in epidemiologic, diagnostic, and prognostic data of CA, especially in India. CA is not as uncommon, as it was perceived earlier. High index of suspicion with the use of novel echocardiographic parameters can identify patients who require further testing to confirm CA. Early diagnosis of CA helps in the early initiation of disease-modifying therapy which improves survival.

Publisher

Medknow

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Cardiac amyloidosis in India: Seek and you will find;Journal of Current Cardiology;2024-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3